Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
19 hedge funds and large institutions have $41.8M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $44.7M → $41.8M (-$2.91M)
27.22% less ownership
Funds ownership: 71.76% → 44.54% (-27%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
19
Holding in Top 10
–
Calls
$10.9M
Puts
$5.05M
Top Buyers
| 1 | +$22.5M | |
| 2 | +$3.29M | |
| 3 | +$1.02M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$896K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$790K |
Top Sellers
| 1 | -$5.62M | |
| 2 | -$2.73M | |
| 3 | -$1.06M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$116K |
| 5 |
GS
GTS Securities
New York
|
-$78.7K |